Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 78

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 78
---
,739 | ​ | ​ | ​ | ​        | ​ | 3,197,384 | ​ | ​ |
| Shawn Cross      | ​ | ​ | ​            | ​ |   525,000 | ​ | ​ | ​ | ​                 | ​ | 18,055 | ​ | ​ | ​ | ​                                  | ​ |       — | ​ | ​ | ​ | ​        | ​ |   543,055 | ​ | ​ |
| Lauren Riker     | ​ | ​ | ​            | ​ |   374,700 | ​ | ​ | ​ | ​                 | ​ | 20,833 | ​ | ​ | ​ | ​                                  | ​ | 196,916 | ​ | ​ | ​ | ​        | ​ |   592,449 | ​ | ​ |
| Kristen Williams | ​ | ​ | ​            | ​ |   519,600 | ​ | ​ | ​ | ​                 | ​ | 15,609 | ​ | ​ | ​ | ​                                  | ​ | 386,936 | ​ | ​ | ​ | ​        | ​ |   922,145 | ​ | ​ |
| Daryl Gaugler    | ​ | ​ | ​            | ​ |   512,000 | ​ | ​ | ​ | ​                 | ​ | 20,833 | ​ | ​ | ​ | ​                                  | ​ | 391,872 | ​ | ​ | ​ | ​        | ​ |   924,705 | ​ | ​ |
| Jonathan Slonin  | ​ | ​ | ​            | ​ |   535,000 | ​ | ​ | ​ | ​                 | ​ | 20,833 | ​ | ​ | ​ | ​                                  | ​ | 427,687 | ​ | ​ | ​ | ​        | ​ |   983,520 | ​ | ​ |

(1) Amounts are based on the fair market value of our common stock of $18.84 per share, which was the closing price of our common stock on December 31, 2024, the last trading day of 2024, as reported on the Nasdaq Global Select Market.

Pacira BioSciences, Inc. 2025 Proxy Statement | 85

TABLE OF CONTENTS Executive Compensation

II. INVOLUNTARY TERMINATION WITHOUT CAUSE OR RESIGNATION FOR GOOD REASON IN CONNECTION WITH A CHANGE OF CONTROL

| Name             | ​ |